It is safe and feasible to conduct a full-scale trial. Whilst iTBS has shown promising results, further research optimizing the intervention is required to improve anticipated clinical efficacy.

The aim of this study was to investigate changes in oxygen saturation (SpO2) occurring during the three days following hip surgery in patients in this hospital and to determine to what extent SpO2 might be improved by oxygen therapy for 24 or 72 hours. Eighty-three patients (aged 43-96 years) scheduled for elective total hip replacement or emergency surgery for hip fractures were studied. Forty-four patients had 24 hour postoperative oxygen prescribed by their anaesthetist or surgeon; we randomized these to either continue oxygen for a total of three days (Group 1) or to discontinue oxygen after Day 1 (Group 2). Patients not prescribed oxygen by the surgeon or anaesthetist (n = 39) were randomly assigned either to receive oxygen for three days (Group 3) or not to receive oxygen (Group 4). Oxygen was administered through nasal cannulae at a flow of 2 l.min−1. SpO2 was measured every 10 seconds for three days and stored on computer disc. Percentage of time spent with SpO2 below 90% was used as an idex of desaturation. Patients receiving oxygen had significantly improved SpO2. In patients not receiving oxygen, desaturation was most severe on Days 1 and 2, improving somewhat on Day 3. On Day 2 desaturation was similar in Groups 2 and 4. When oxygen was not being administered males were significantly more desaturated than females. Our investigations indicate that following hip surgery poor saturation continues for at least two days and can be improved by oxygen therapy.

SummaryA system was developed to test the accuracy of patient-controlled analgesia devices in situations simulating clinical use. Bolus requests are made automatically at predetermined intervals, and the infusate delivered is measured and recorded without the need for operator presence. To ensure clinical relevance, the bolus request times used in this study corresponded to a pattern typical of those requested by patients on the ward. Graseby, Abbott Provider 5.500 and W A C patient-controlled analgesia devices were tested and found to deliver reasonably accurately over a 24 h period. However, when an infusion was started in an unprimed system or afer a period of no bolus requests in a bolus-only mode the Graseby and W A C machines under-delivered. This system provides a means of testing patient-controlled analgesia devices operating in any delivery mode.

Aim Randomized trials comparing surgical techniques for rectal prolapse are not always feasible. We assessed whether non-randomized comparisons of those who have had surgery with those still waiting would be confounding baseline health status. Method This was a prospective cohort study in seven UK hospitals. Participants were ≥ 18 years and listed for surgical interventions of equivalent intensity for rectal prolapse. They were defined as short or long waiters (≤ 18 or > 18 weeks, respectively). Time on the waiting list was compared with baseline comorbidity (Charlson comorbidity index) and change from baseline in health status (EQ-5D-5L) at the time of surgery. Results In all, 203 patients were analysed. Median (interquartile range) waiting time was 13.7 weeks (8.1, 20.4) varying across sites. Baseline comorbidity was not an important predictor of waiting time. Median Charlson comorbidity index was 2 (0, 3) for short and 1 (0, 3) for long waiters. A change in waiting time by a week was associated with negligible improvement in the EQ-5D-5L index of 0.001 (95% CI −0.000 to 0.003, P = 0.106). Conclusion Negligible change in patient reported health status while on the waiting list and lack of effect of comorbidities in influencing waiting time support the use of non-randomized pre-/post-studies to compare the effects of surgical interventions for rectal prolapse.